C&O is pleased to be appointed by Shantou Meiji Pharmaceutical Co., Ltd., a subsidiary of Tokyo-listed Meiji Seika Kaisha, Ltd. (“Meiji Seika Kaisha”), as the distributor of its new-generation cephalosporin, Meiact.